Glaxosmithkline Pharmaceuticals Ltd.
Snapshot View

1264.95 +2.00 ▲0.2%

27 January 2023, 04:01:00 PM
Volume: 2,926

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gsk-india.com
Market Cap 21,372.27 Cr.
Enterprise Value(EV) 20,672.35 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 99.29 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 12.74 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 85.88 Trailing Twelve Months Ending 2022-09
Price to Book Value 14.73 Calculated using Price: 1,264.95
Dividend Yield 7.13 Period Ending 2022-03
No. of Shares Subscribed 16.94 Cr. 169,406,034 Shares
FaceValue 10
Company Profile
The company is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company's Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.16%
1 Week
-1.96%
1 Month
-4.92%
3 Month
-7.50%
6 Month
-12.61%
1 Year
-22.59%
2 Year
-13.89%
5 Year
+3.06%
10 Year
+22.47%
9 years 2013-12 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 24.10 24.95 18.75 16.08 17.26 21.22 4.71 17.42 18.39
Return on Capital Employed (%) 35.54 39.53 28.81 24.39 26.56 32.54 15.76 27.74 37.72
Return on Assets (%) 15.95 15.44 7.84 5.16 4.93 5.77 1.72 9.52 10.11

Balance Sheet View Details >>

Particulars 10 years 2013-12 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1,990 1,829 2,183 2,007 2,057 2,140 1,821 1,478 2,663 1,455
Non Curr. Liab. 159 197 3,498 3,700 2,632 2,860 180 179 159 145
Curr. Liab. 889 1,107 784 881 2,949 2,804 1,022 1,355 1,698 1,295
Minority Int.
Equity & Liab. 3,037 3,133 6,465 6,588 7,639 7,804 3,023 3,012 4,520 2,895
Non Curr. Assets 413 546 4,087 4,753 4,103 4,445 1,248 809 812 700
Curr. Assets 2,624 2,587 2,378 1,835 3,536 3,359 1,775 2,203 3,708 2,195
Misc. Exp. not W/O
Total Assets 3,037 3,133 6,465 6,588 7,639 7,804 3,023 3,012 4,520 2,895

Profit Loss View Details >>

Particulars 10 years 2013-12 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 2,608 3,363 2,838 2,908 2,871 3,128 3,224 2,926 3,278 3,288
Other Income 222 259 123 73 55 102 79 111 76 79
Total Income 2,830 3,622 2,961 2,982 2,926 3,230 3,303 3,036 3,354 3,366
Total Expenditure -2,124 -2,788 -2,360 -2,489 -2,366 -2,527 -2,567 -2,327 -2,516 -2,509
PBIDT 706 833 601 492 560 703 736 709 838 858
Interest 0 0 0 0 0 -1 -6 -4 -2 -2
Depreciation -20 -25 -25 -26 -38 -49 -83 -79 -68 -65
Taxation -230 -279 -202 -174 -189 -237 -213 -167 -398 -409
Exceptional Items 26 -52 2 46 18 29 -341 -173 12 12
PAT 482 476 376 337 351 445 93 287 381 393
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 482 476 376 337 351 445 93 358 1,695 1,682
Adjusted EPS 28 28 22 20 21 26 6 21 100 99

Cash Flow View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2013-12 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 314 281 338 139 234 473 409 491 578 811
Cash Fr. Inv. -110 189 180 499 301 -104 -153 -57 418 -406
Cash Fr. Finan. -441 -494 -497 -638 -511 -307 -358 -428 -696 -524
Net Change -237 -24 21 0 24 62 -102 6 300 -119
Cash & Cash Eqvt 138 114 116 115 139 201 99 105 405 286

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 11 Jan 2023
Board Meeting Intimation for Un- Audited Financial Results For The Third Quarter & Nine Months Ended 31St December 2022
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2023 inter alia to consider and approve Un- Audited Financial Results for the third quarter & nine months ended 31st December 2022
Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate pursuant to Regulation 74(5)
Thu, 29 Dec 2022
Closure of Trading Window
Closure of Trading window

Technical Scans View Details >>

Fri, 27 Jan 2023
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Glaxosmithkline Pharmaceuticals Ltd.

What is Glaxosmithkline Phar share price?

Can I buy Glaxosmithkline Phar shares now?

What is the Dividend Yield of Glaxosmithkline Phar?

What is the Market Cap of Glaxosmithkline Phar?

What are the key metrics to analyse Glaxosmithkline Phar?

What is the 52 Week High and Low of Glaxosmithkline Phar?

What is the trend of Glaxosmithkline Phar share price?